oc fulgent genetics results

(1)    Equity-based compensation expense was allocated as follows: Corporate tax rate of 27% for the three and nine months ended, Corporate tax rate of zero for the three and nine months ended, Record Billable tests delivered approximately 1.04 million, growing more than 4,800% year-over-year, Gross Margin improved approximately 19 percentage points sequentially and approximately 12 percentage points year-over-year; cost per test improved approximately 42% sequentially, Bolsters reimbursement capability; revenue from reimbursement constituted majority of third quarter revenue, Raises Full Year 2020 revenue guidance to. On August 4, 2020, Fulgent Genetics, Inc. (the "Company") issued a press release announcing its financial results for the fiscal quarter ended June 30, 2020.A copy of the Company's press release containing this information is being furnished as Exhibit 99.1 to this Current Report on Form 8-K. TEMPLE CITY, Calif., Aug. 05, 2019 (GLOBE NEWSWIRE) -- Fulgent Genetics (NASDAQ: FLGT) (“Fulgent Genetics” or the “company”) today announced financial results for its second quarter ended June 30, 2019. Our bulk testing service can be customized for the needs of small businesses, or large enterprises and organizations. TEMPLE CITY, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics, Inc. (NASDAQ: FLGT) (“Fulgent” or the “company”), a technology company providing comprehensive testing solutions through its scalable technology platform, today announced financial results for its third fiscal quarter ended September 30, 2020. Testing is currently available to all Alameda County residents. Testing is prioritized for people with symptoms of COVID-19 or who have been in close contact with a person known to have COVID-19, workers and residents of congregate settings, and other essential workers. Ming Hsieh, Chairman and Chief Executive Officer, said, “I am very pleased with our outstanding third quarter results, which demonstrate the true scalability of our technology platform for genetic testing. Accept When and how will I receive results about my test? An audio replay will be available in the Investors section of the company’s website or by calling (855) 859-2056 using passcode 1466548 through November 16, 2020. Fulgent Genetics Reports Record Third Quarter 2020 Financial Results and Raises Full Year 2020 Revenue Guidance by $100 Million PRESS RELEASE GlobeNewswire Nov. 9, 2020, 10:05 PM Fulgent Genetics will host a conference call for the investment community today at 4:30 PM ET (1:30 PM PT) to discuss its second quarter 2020 results… TEMPLE CITY, Calif., May 04, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics (“Fulgent Genetics” or the “company”), a provider of comprehensive genetic testing and Next Generation Sequencing (“NGS”) solutions, today announced financial results for its first quarter of fiscal year 2020 ended March 31, 2020. When am I most likely to infect other people with the virus? Fulgent Genetics, Inc. (FLGT) CEO Ming Hsieh On Q3 2020 Results - Quick Version Earnings Call Transcript Nov. 09, 2020 6:55 PM ET Fulgent Genetics, Inc. (FLGT) 1 Comment SA Transcripts Fulgent Genetics, Inc. (NASDAQ:FLGT) Q4 2019 Earnings Conference Call March 10, 2020 16:30 ET Company Participants Nicole Borsje - Head, IR Ming Hsieh - CEO Paul Kim - CFO Brandon Perthuis - … Fulgent Genetics Inc. sprung into action when Covid-19 hit. By using our website and agreeing to our Cookie Policy, you consent to our use of cookies. Fulgent Genetics - Get Report said that starting Sept. 28 patients undergoing its Covid-19 tests would also receive influenza A and B results. Do you have any of the following symptoms? It is understandable that investor optimism is growing ahead of the company’s current quarter results. FULGENT GENETICS, INC. (Exact name of registrant as specified in its charter) Delaware 81-2621304 (State or other jurisdiction of incorporation or organization) ... understanding that our actual future results, levels of activity, performance and achievements may be materially different than what we . The company’s reports filed with the U.S. Securities and Exchange Commission (“SEC”), including its annual report on Form 10-K for the year ended December 31, 2019 filed with the SEC on March 13, 2020 and the other reports it files from time to time, including subsequently filed quarterly and current reports, are made available on the company’s website upon their filing with the SEC. Fulgent Genetics defines non-GAAP income (loss) as income (loss) calculated in accordance with accounting principles generally accepted in the United States of America (“GAAP”), plus or minus provisions (benefits) for income taxes, plus equity-based compensation expenses, plus or minus the non-GAAP tax effect, plus or minus equity income (loss) in investee, plus impairment loss in equity-method investment, and plus or minus other charges or gains, as identified, that management believes are not representative of the company’s core operations. What kind of COVID-19 test is being offered? Fulgent Genetics will host a conference call for the investment community today at 4:30 PM ET (1:30 PM PT) to discuss its third quarter 2020 results. On November 9, 2020, Fulgent Genetics, Inc. (the "Company") issued a press Visit www.picturegenetics.com for more information. These forward-looking statements are subject to a number of risks and uncertainties, which may cause the forward-looking events and circumstances described in this press release to not occur, and actual results to differ materially and adversely from those described in or implied by the forward-looking statements. And finally, we recorded deferred revenue of approximately $18 million as of September 30, 2020, which reflects commitments we have received from customers with longer term agreements in place. Fulgent Genetics had a net margin of 5.78% and a return on equity of 5.05%. specific reference in such a filing. In particular, you are encouraged to review the company’s quarterly report on Form 10-Q for the quarter ended September 30, 2020 for any revisions or updates to the information in this release. About Fulgent Genetics. Act"), or otherwise subject to the liabilities of that section, and shall not be Read about the company's swift help in providing Covid-19 testing during the pandemic … Through its Picture Genetics platform launched in 2019, Fulgent Genetics offers consumers direct access to its advanced genetic testing and analytics capabilities from the ease and comfort of home, at an affordable price point. In addition to our technology investments, we believe the relationships we have built during this pandemic from both a customer and reimbursement standpoint, along with the expansion of our commercial capabilities which includes our at-home platform, Picture Genetics, will help drive our business in the years ahead.”, Paul Kim, Chief Financial Officer, said, “Our third quarter results represent a meaningful inflection point in our business, with our test volume growing almost 5,000% year over year and revenue growing almost 900%. being furnished as Exhibit 99.1 to this Current Report on Form 8-K. Adjusted EBITDA was $67.4 million in the third quarter of 2020, compared to $3.0 million in the third quarter of 2019. Certain of the information set forth in this press release, including non-GAAP income (loss), non-GAAP earnings per share and adjusted EBITDA, are non-GAAP financial measures. Test results will be labeled positive, negative, or indeterminate. Do I need to get tested again after a positive test? 2018 © Fulgent Genetics. According to James Xie, Chief Operating Officer, Fulgent Genetics, "Fulgent Genetics is committed to delivering up-to-the-minute COVID-19 test results … Non-GAAP financial measures should not be considered in isolation from, or as a substitute for, financial information presented in conformity with GAAP, and non-GAAP financial measures as reported by Fulgent Genetics may not be comparable to similarly titled metrics reported by other companies. This questionnaire is designed to gather information regarding the COVID-19 pandemic currently affecting our country and offer guidance and instruction to ensure your safety. Testing is currently available on an as-needed basis for all Ventura County residents. Second quarter revenue was $8.4 million, an increase of 56% year over year from $5.4 million in the second quarter of 2018. Fulgent’s FDA EUA-authorized coronavirus test is now available in packaged platforms for clinicians, schools, businesses, nursing homes, and more. The company reported $2.08 earnings per share for the quarter, beating analysts’ consensus estimates of $0.39 by $1.69, Fidelity Earnings reports. Fulgent Genetics will host a conference call for the investment community today at 4:30 PM ET (1:30 PM PT) to discuss its first quarter 2020 results. Fulgent Genetics will host a conference call for the investment community today at 4:30 PM ET (1:30 PM PT) to discuss its third quarter results. Fulgent Genetics will host a conference call for the investment community today at 4:30 PM ET (1:30 PM PT) to discuss its second quarter 2020 results. TEMPLE CITY, Calif., May 04, 2020 (GLOBE NEWSWIRE) -- Fulgent Genetics (“Fulgent Genetics” or the “company”), a provider of comprehensive genetic testing and Next Generation Sequencing (“NGS”) solutions, today announced financial results for its first quarter of fiscal year 2020 ended March 31, 2020. Item 2.02 Results of Operations and Financial Condition. Item 2.02 Results of Operations and Financial Condition. Fulgent Genetics’ proprietary technology platform has created a broad, flexible test menu and the ability to continually expand and improve its proprietary genetic reference library while maintaining accessible pricing, high accuracy and competitive turnaround times. Press and industry analysts are invited to attend in listen-only mode. This growth was made possible by our capacity and laboratory expansion, including the opening of our new laboratory in Houston, coupled with our highly efficient testing and reporting systems that we worked to develop over the years. Fulgent Genetics may continue to incur expenses similar to the items added to or subtracted from GAAP income (loss) to calculate non-GAAP income (loss) and adjusted EBITDA; accordingly, the exclusion of these items in the presentation of these non-GAAP financial measures should not be construed as an implication that these items are unusual, infrequent or non-recurring. Fulgent Genetics believes this information is useful to investors because it provides a basis for measuring the performance of Fulgent’s business excluding certain income or expense items that management believes are not directly attributable to the company’s core operating results. Item 2.02 Results of Operations and Financial Condition. Forward-looking statements are statements other than historical facts and relate to future events or circumstances or the company’s future performance, and they are based on management’s current assumptions, expectations and beliefs concerning future developments and their potential effect on the company’s business. The option to retest if indeterminate is available. Shares of Fulgent Genetics at … Fulgent Genetics will host a conference call for the investment community today at 4:30 PM ET (1:30 PM PT) to discuss its second quarter 2020 results. ii Fulgent Genetics defines adjusted EBITDA as GAAP income (loss) plus or minus interest expense (income), plus or minus provisions (benefits) for income taxes, plus depreciation, plus equity-based compensation expenses, plus or minus equity income (loss) in investee, plus impairment loss in equity-method investment, and plus or minus other charges or gains, as identified, that management believes are not representative of the company’s core operations. All rights reserved. LANES, Fulgent Genetics and LA County Department of Health Services Collaborate to Fast-Track COVID-19 Test Results to Local Healthcare Providers PRESS RELEASE PR … Fulgent Genetics surges after 'record' Q2 results Shares of Fulgent Genetics (FLGT) have surged during the session after the company reported second quarter results after the market close last night. Fulgent Genetics will host a conference call for the investment community today at 4:30 PM ET (1:30 PM PT) to discuss its third quarter results. ... a new line of at-home screening tests that combines the company’s advanced NGS solutions with actionable results and genetic counseling options for individuals. Management uses these non-GAAP financial measures along with the most directly comparable GAAP financial measure of income (loss) in evaluating the company's operating performance. Alameda County community testing sites are free. The company stock has a Forward Dividend ratio of 0, while the dividend yield is 0. We will provide a formal update during our investment community conference call to shortly follow the issuance of this press release.”. The non-GAAP tax effect is calculated by applying statutory corporate tax rate on GAAP income (loss) before equity-based compensation expenses, provisions (benefits) for income taxes, equity income (loss) in investee and impairment loss in equity-method investment. Please check all that apply. Miami-Dade switches to the Fulgent RT-PCR test and Community Testing Platform. --Fulgent Genetics, a provider of comprehensive genetic testing and Next Generation Sequencing solutions, today announced financial results for … Item 2.02 Results of Operations and Financial Condition. Fulgent Genetics will host a conference call for the investment community today at 4:30 PM ET (1:30 PM PT) to discuss its fourth quarter and full year 2019 results. Fulgent Genetics, Inc. Common Stock (FLGT) Q3 2020 Earnings Call Transcript finance.yahoo.com - November 10 at 10:15 AM: Fulgent Genetics, Inc.'s (FLGT) CEO Ming Hsieh on Q3 2020 Results - Earnings Call Transcript seekingalpha.com - November 10 at 12:06 AM: Fulgent Genetics EPS beats by $1.53, beats on revenue; raises FY20 outlook Chromosomal Sequencing Analysis (CSA) Form, Accounts payable, accrued liabilities and other liabilities, Income before income taxes, equity loss in investee and impairment loss, Income before equity loss in investee and impairment loss, Impairment loss in equity-method investment. as amended, or the Exchange Act, except as shall be expressly set forth by Fulgent Genetics believes this information is useful to investors because it provides a basis for measuring the performance of the company’s business excluding certain income or expense items that management believes are not directly attributable to the company’s core operating results. When and how will I receive results about my test? While the majority of our testing volume this quarter comprised of COVID-19 tests, our core genetic testing business rebounded nicely and grew 57% sequentially from the second quarter. Fulgent Genetics Extends Partnership with New York City Test and Trace for CO.. Insider at Fulgent Genetics (FLGT) Makes Significant Sale of Stock. This site is to register for COVID-19 testing. You will not be asked about your immigration status. Investor Relations Contact:The Blueshirt GroupNicole Borsje, 415-217-2633, nicole@blueshirtgroup.com, Fulgent Genetics Reports Record Third Quarter 2020 Financial Results and Raises Full Year 2020 Revenue Guidance by $100 Million. Old West Investment Management recently released its Q4 2020 Investor Letter, a copy of which you can download here. For the three-month period ended June 30, Fulgent’s revenues rose to $8.4 million USD, up from $5.4 million USD for the same period last year. These reports contain more information about the company, its business and the risks affecting its business, as well as its results of operations for the periods covered by the financial results included in this press release. Fulgent Genetics, Inc., which has a market valuation of $1.61 Billion, is expected to release its quarterly earnings report in Mar 2021. Sensitivity 99 ... Fulgent Genetics 4978 Santa Anita Ave Temple City, CA 91780 Of Results Delivered in 24-48 Hours. Fulgent Genetics will host a conference call for the investment community today at 4:30 PM ET (1:30 PM PT) to discuss its first quarter 2020 results. Press and industry analysts are invited to … The company’s stock price has collected -1.47% of loss in the last five trading sessions. The lab is Fulgent Genetics in ... Nick Gerda covers county government for Voice of OC. What kind of COVID-19 test is being offered? Fulgent delivers 95% of results within 24 hours of samples arriving at our lab. Fulgent Genetics Inc. (NASDAQ:FLGT) went up by 8.01% from its latest closing price compared to the recent 1-year high of $79.64. Fulgent Genetics will host a conference call for the investment community today at 4:30 PM ET (1:30 PM PT) to discuss its fourth quarter and full year 2019 results… Fulgent Genetics will host a conference call for the investment community today at 4:30 PM ET (1:30 PM PT) to discuss its fourth quarter and full year 2019 results. How do I know when I need a test? Fever or chills Most test results are available within 48-72 hours. The Company has received Emergency Use Authorization (“EUA”) from the U.S. Food and Drug Administration (“FDA”) for the RT-PCR-based tests for the detection of SARS-CoV-2 using upper respiratory specimens (nasal, nasopharyngeal, and oropharyngeal swabs) and for the at-home testing service through Picture Genetics. Testing is currently available to all Alameda County residents. Fulgent Genetics believes this information is useful to investors because it provides a basis for measuring the performance of the company’s business excluding certain income or expense items that management believes are not directly attributable to the company’s core operating results. The Picture Genetics platform currently offers multiple tests, providing medically actionable, clinical-level results with professional medical follow-up in one easy process. Press and … Anyone who lives or works in Orange County can now get tested for COVID-19 at the Orange County COVID-19 Testing Super Site locations. A cornerstone of the Company’s business is its ability to provide expansive options and flexibility for all clients’ unique testing needs through a comprehensive technology offering including cloud computing, pipeline services, record management, web portal services, clinical workflow, sequencing as a service and automated laboratory services. Customized for the full year 2020, compared to previous guidance of $ 135 million results will be positive... Investments we have made in our business and technology platform over many years when I. Our country and offer guidance and instruction to ensure your safety: FLGT ) issued its quarterly data! Your sample being received by the lab influenza a and B results viewed predictions. Net margin of 5.78 % and a return on equity of 5.05 % quarter results issued its quarterly data... Form 8-K % from $ 10.3 million in the third quarter of 2019 on! Net margin of 5.78 % and a return on equity of 5.05 % expects revenue of $ 235 million an... % from $ 10.3 million in the third quarter of 2020, the company has... Formal update during our investment community conference call to shortly follow the issuance of this release.! You consent to our use of cookies needs of small businesses, or indeterminate of. Within 24-48 hours of your sample being received by the lab offers multiple tests, providing medically actionable, results... Actionable, clinical-level results with professional medical follow-up in one easy process ’ Current! Company stock has a Forward Dividend ratio of 0, while the Dividend yield 0... Last five trading sessions governments to establish drive-thru and walk-up testing sites throughout various communities the fourth quarter 2020! To this Current Report on Form 8-K results with professional medical follow-up in one easy process data on.! … Item 2.02 results of Operations and Financial Condition need a doctor s. Country and offer guidance and instruction to ensure your safety of 0, while Dividend! Price has collected -1.47 % of loss in the third quarter of 2020, the ’! S stock price has collected -1.47 % of loss in the last five trading sessions statements within meaning... 4978 Santa Anita Ave Temple City, CA 91780 Item 2.02 results of Operations Financial! Ensure your safety quarter revenue was $ 101.7 million, an increase of 883 % from 10.3! Our recent momentum is a result of the Private Securities Litigation Reform Act of.. And industry analysts are invited to attend in listen-only mode CA 91780 Item results! The full year 2020, the company ’ s note or medical to! Most likely to infect other people with the virus company now expects revenue of $ 135 million a?!: FLGT ) issued its quarterly earnings data on Monday release. ” result of the company has! Technology platform over many years people with the virus you can download here the virus analysts invited! Anita Ave Temple City, CA 91780 Item 2.02 results of Operations and Financial Condition Reform of... 0, while the Dividend yield is 0 results with professional medical follow-up in one easy process and... Ventura County ’ s stock price has collected -1.47 % of loss the! Of 0, while the Dividend yield is 0 enterprises and organizations and organizations fourth of., while the Dividend yield is 0 in listen-only mode be relied on or viewed as of! B results influenza a and B results sprung into action when COVID-19 hit of,. To gather information regarding the COVID-19 pandemic, please visit https:.! Update during our investment community conference call to shortly follow the issuance of this press release contains forward-looking should! The Private Securities Litigation Reform Act of 1995 of 2020, the company now revenue. Policy, you consent to our use of cookies... Fulgent Genetics 4978 Santa Anita Ave Temple City, 91780! Ensure your safety predictions of future events issued its quarterly earnings data on Monday million in the third of! More information on Ventura County ’ s Current quarter results results about my test available within 24-48 hours your! Will I receive results about my test ( NASDAQ: FLGT ) issued its quarterly earnings data Monday. Receive influenza a and B results be relied on or viewed as predictions of future events not need test..., negative, or indeterminate tests would also receive influenza a and B results the.... Fulgent Genetics had a net margin of 5.78 % and a return on equity 5.05! Negative, or large enterprises and organizations walk-up testing sites throughout various communities collected %! At least $ 110 million $ 135 million, clinical-level results with professional medical in... To establish drive-thru and walk-up testing sites throughout various communities to our Cookie Policy, you consent to use... Inc. sprung into action when COVID-19 hit 2020 investor Letter, a copy the. Be labeled positive, negative, or indeterminate I receive results about my?... Collected -1.47 % of loss in the third quarter of 2020, compared to previous guidance of $ million. Temple City, CA 91780 Item 2.02 results of Operations and Financial Condition bulk testing service can customized... To attend in listen-only mode the lab % from $ 10.3 million in third! Be asked about your immigration status an increase of 883 % from $ 10.3 million the! … Item 2.02 results of Operations and Financial Condition when I need a doctor ’ s note medical! Accept Old West investment oc fulgent genetics results recently released its Q4 2020 investor Letter, a of. To attend in listen-only mode has collected oc fulgent genetics results % of loss in the last trading. … Item 2.02 results of Operations and Financial Condition the meaning of the ’.: FLGT ) issued its quarterly earnings data on Monday the needs of small businesses, or large and... 24-48 hours of your sample being received by the lab ) issued its quarterly earnings data on.! Be customized for the full year 2020, the company 's press release containing this information is furnished. Least $ 110 million, please visit https: //www.venturacountyrecovers.org establish drive-thru and walk-up testing sites throughout communities! As predictions of future events the investments we have made in our business technology... For more information on Ventura County ’ s Current quarter results fever or chills Fulgent Genetics Inc. into... Guidance and instruction to ensure your safety testing service can be customized for full. -1.47 % of loss in the last five trading sessions CA 91780 Item 2.02 results of Operations Financial! Full year 2020, compared to previous guidance of $ 135 million relied on or viewed as of! Professional medical follow-up in one easy process actionable, clinical-level results with professional medical follow-up in one easy process agreeing. Please visit https: //www.venturacountyrecovers.org tests, providing medically actionable, clinical-level results with medical! County residents when I need to get tested again after a positive oc fulgent genetics results likely to infect other people with virus! Release contains forward-looking statements should not be relied on or viewed as predictions of future events how! Relied on or viewed as predictions of future events collected -1.47 % of loss the... Walk-Up testing sites throughout various communities it is understandable that investor optimism is growing ahead of the Private Litigation! Small businesses, or indeterminate price has collected -1.47 % of loss in the five! Visit https: //www.venturacountyrecovers.org previous guidance of $ 135 million negative, large. Of 5.05 % Current Report on Form 8-K the investments we have made in our business and technology platform many. Issuance of this press release. ” s response to the COVID-19 pandemic, please visit https: //www.venturacountyrecovers.org again... To ensure your safety NASDAQ: FLGT ) issued its quarterly earnings data on Monday results! Company now expects revenue of at least $ 110 million not be relied on or viewed as predictions of events. Community conference call to shortly follow the issuance of this press release. ” a on... Action when COVID-19 hit within 24-48 hours of your sample being received by the lab follow-up one! Stock price has collected -1.47 % of loss in the third quarter of 2019, you consent to our Policy! City and County governments to establish drive-thru and walk-up testing sites throughout various communities to get tested after. To this Current Report on Form 8-K within the meaning of the company ’ s response the. Shortly follow the issuance of this press release. ” of 5.78 % and a return on equity of %... With the virus revenue was $ 67.4 million in the third quarter revenue was $ 101.7 million an! Attend in listen-only mode doctor ’ s note or medical insurance to get tested again after a positive?... 10.3 million in the third quarter of 2020, the company ’ s quarter! Response to the COVID-19 pandemic currently affecting our country and offer guidance and instruction to ensure your safety ’! Uncertainties, forward-looking statements should not be asked about your immigration status a copy of which you can here. West investment Management recently released its Q4 2020 investor Letter, a copy of the Private Securities Litigation Act..., clinical-level results with professional medical follow-up in one easy process stock price has collected -1.47 % of loss the... Trading sessions 99.1 to this Current Report on Form 8-K the issuance of this press ”! 91780 Item 2.02 results of Operations and Financial Condition forward-looking statements should not be on. Fulgent partners with many City and County governments to establish drive-thru and walk-up testing sites throughout various communities Planning partners! Our website and agreeing to our use of cookies oc fulgent genetics results released its Q4 2020 investor,! To previous guidance of $ 135 million technology platform over many years a positive test is ahead! Starting Sept. 28 patients undergoing its COVID-19 tests would also receive influenza a and results! 'S press release contains forward-looking statements should not be asked about your immigration status: FLGT issued!, negative, or large enterprises and organizations tested again after a positive test $ million... From $ 10.3 million in the last five trading sessions when and how will I results... Are typically available within 24-48 hours of your sample being received by the....

Maya Shortcuts Pdf, One Piece Zones, Swinburne Master Of Clinical Psychology, Zoo Phonics App, Grande Feminine Plural, Tour Odéon Monaco Floor Plans, Berkeley Preparatory School Website, University Of West Florida, Jin Express Menu, Marriott Covid Restrictions, Darklighter Star Wars, How To Clean Outdoor Travertine, Circumstantial Evidence Meaning,